A detailed history of Northstar Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northstar Asset Management LLC holds 5,698 shares of BMY stock, worth $307,464. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,698
Previous 6,098 6.56%
Holding current value
$307,464
Previous $330,000 28.48%
% of portfolio
0.06%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$40.25 - $52.99 $16,100 - $21,196
-400 Reduced 6.56%
5,698 $236,000
Q1 2024

Apr 26, 2024

BUY
$47.98 - $54.4 $28,787 - $32,640
600 Added 10.91%
6,098 $330,000
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $16,968 - $20,247
350 Added 6.8%
5,498 $282,000
Q3 2023

Oct 25, 2023

BUY
$57.89 - $64.73 $46,312 - $51,784
800 Added 18.4%
5,148 $298,000
Q2 2023

Jul 28, 2023

BUY
$63.71 - $70.74 $30,517 - $33,884
479 Added 12.38%
4,348 $278,000
Q1 2023

Apr 24, 2023

BUY
$65.71 - $74.53 $50,530 - $57,313
769 Added 24.81%
3,869 $268,000
Q2 2022

Jul 20, 2022

SELL
$72.62 - $79.98 $43,572 - $47,988
-600 Reduced 16.22%
3,100 $239,000
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $6,191 - $6,742
100 Added 2.78%
3,700 $247,000
Q4 2020

Jan 21, 2021

SELL
$57.74 - $65.43 $2,887 - $3,271
-50 Reduced 1.37%
3,600 $223,000
Q1 2020

Apr 20, 2020

BUY
$46.4 - $67.43 $6,960 - $10,114
150 Added 4.29%
3,650 $203,000
Q4 2019

Jan 16, 2020

BUY
$49.21 - $64.19 $172,235 - $224,665
3,500 New
3,500 $225,000
Q4 2018

Feb 04, 2019

SELL
$48.76 - $63.23 $314,550 - $407,896
-6,451 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$55.19 - $62.25 $1,158 - $1,307
21 Added 0.33%
6,451 $400,000
Q2 2018

Aug 22, 2018

SELL
$50.53 - $62.98 $213,236 - $265,775
-4,220 Reduced 39.62%
6,430 $356,000
Q1 2018

May 02, 2018

BUY
$59.92 - $68.98 $5,992 - $6,898
100 Added 0.95%
10,650 $673,000
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $582,676 - $672,457
10,550
10,550 $672,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northstar Asset Management LLC Portfolio

Follow Northstar Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northstar Asset Management LLC with notifications on news.